Skip to main content
. 2021 Oct 9;43(3):558–582. doi: 10.1210/endrev/bnab035

Figure 2.

Figure 2.

PCSK9 inhibition. Monoclonal Abs and siRNAs are safe and temporary inhibitors of PCSK9. Irreversible inhibition may be achieved through vaccination or PCSK9 gene modification via CRISPR-Cas. Finally, a more affordable inhibition based on orally active inhibitors is in development. See text for references.